Product Images Sevelamer Carbonate
View Photos of Packaging, Labels & Appearance
- Figure 2. Change in serum phosphorus (mg/dL) from baseline to Week 2 by subgroup - sevelamer fig1
- Figure 3. Percentage of patients (Y-axis) attaining a phosphorus reduction from baseline (mg/dL) at least as great as the value of the X-axis. - sevelamer fig2
- Figure 4. Mean Phosphorus Change from Baseline for Patients who Completed 52 Weeks of Treatment - sevelamer fig3
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 800 mg (270 Tablets Bottle) - sevelamer fig4
- Chemical Structure - sevelamer str
Product Label Images
The following 5 images provide visual information about the product associated with Sevelamer Carbonate NDC 16714-814 by Northstar Rx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 2. Change in serum phosphorus (mg/dL) from baseline to Week 2 by subgroup - sevelamer fig1
Figure 3. Percentage of patients (Y-axis) attaining a phosphorus reduction from baseline (mg/dL) at least as great as the value of the X-axis. - sevelamer fig2
The text describes a figure showing the percentage of patients who achieved a reduction in serum phosphorus levels (mg/dL) compared to baseline. The Y-axis represents the percentage of patients, while the X-axis shows the reduction in serum phosphorus levels. The figure includes data for both an active group and a control group.*
Figure 4. Mean Phosphorus Change from Baseline for Patients who Completed 52 Weeks of Treatment - sevelamer fig3
This figure shows the mean change in phosphorus levels among patients who completed 52 weeks of treatment with Sevelamer Hydrochloride compared to an active control. The graph indicates the phosphorus change from the baseline at different study weeks, with week 0 being the baseline.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 800 mg (270 Tablets Bottle) - sevelamer fig4
Each film-coated tablet contains 800mg of sevelamer carbonate as an active ingredient, manufactured by Northstar Rx LLC in Memphis, TN. The inactive ingredients are acetylated monoglycerides, ammonium hydroxide, black iron oxide, colloidal silicon dioxide, crospovidone, giyceryl dibehenate, hydroxypropyl cellulose, hypromellose, and talc. The usual dosage is as per the package insert, and the tablets should be stored at 20°C to 26°C (68°F to 77°F) in a tightly closed container protected from moisture. The tablet's total quantity is 270, and the manufacturing date is not specified.*
Chemical Structure - sevelamer str
This is a chemical structure of Sevelamer Carbonate where it is composed of 9 primary amine groups and 1 crosslinking group which forms an extended polymer network. No other information is available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
